Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 4OTHER_GOV 2NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplasms 2Colorectal Neoplasms 2Sarcopenia 1Insulin Resistance 1Colonic Neoplasms 1Cachexia 1

Interventions

Irinotecan 11Oxaliplatin 8Cetuximab 7Fluorouracil 6Leucovorin 5Bevacizumab 5Standard of Care 4S 1 (combination) 4Capecitabine 4trifluridine tipiracil drug combination 2tislelizumab 2apatinib 2Propranolol 2Preoperative Exercise 2Panitumumab 2Levoleucovorin 2Folfox protocol 2Etodolac 2Endoscopic Mucosal Resection 2Drug Therapy 2Chemotherapy, Adjuvant 2trebananib 1regorafenib 1envafolimab 1Trifluridine 1Thalidomide 1Surveys and Questionnaires 1Occult Blood 1Neoadjuvant Therapy 1Moxibustion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Colorectal Neoplasms × Preoperative Exercise × Clear all
NCT04595604 2024-11-29

Prehab_2

St. Borbala Hospital

Phase NA Completed
500 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03758209 2020-03-17

PrehabVsERAS

St. Borbala Hospital

Phase NA Completed
184 enrolled
Gastrointestinal

Insulin Resistance, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡